Fingerprint
Dive into the research topics of 'Crizotinib in patients with tumors harboring ALK or ROS1 rearrangements in the NCI-MATCH trial'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
A. S. Mansfield, Z. Wei, R. Mehra, A. T. Shaw, C. H. Lieu, P. M. Forde, A. E. Drilon, E. P. Mitchell, J. J. Wright, N. Takebe, E. Sharon, D. Hovelson, S. Tomlins, J. Zeng, K. Poorman, N. Malik, R. J. Gray, S. Li, L. M. McShane, L. V. Rubinstein
Research output: Contribution to journal › Article › peer-review